Skip to content
Search

Latest Stories

Submit Guest Post

Shah Rukh Khan's Zero is a romantic sci-fi movie

There's a lot of hype surrounding Shah Rukh Khan starrer Zero.

Not much is known about the plot of the movie, but it has now been revealed that Zero is a romantic film that also has a science fiction angle. According to a report, there's an outer space element in the movie and it's going to be sensational.


Zero stars SRK as a dwarf and his two leading ladies are Katrina Kaif and Anushka Sharma. This will be the first time since 2012's Jab Tak Hai Jaan the trio will be seen together in a movie. However, they do not have a single scene together, reports noted.

Although SRK has been getting a lot of attention for his unique role, Sharma and Kaif's characters are also distinctive.

"While everyone thinks that only Shah Rukh Khan has a special role in the film with a disability, they will be surprised to know that Anushka and Katrina's characters also face various challenges," a source told India Today. "While everyone knows Katrina plays a diva, nobody knows that she is also an alcoholic in the film. She battles with alcoholism, which affects her life in various ways. Anushka, on the other hand, plays a struggling scientist. The makers are trying to keep these details a secret because they don't want to give out too much information," the source added.

Zero is directed by Anand L Rai, who is best known for Tanu Weds Manu and Raanjhanaa.

In an earlier interview with a popular media outlet, Rai said he wanted to celebrate beauty of incompleteness with Zero.

"I wanted to celebrate 'Zero', I wanted to celebrate the incompleteness in people. There is nothing great in being a complete person. There is a beauty to incompleteness. We all are humans and Zero comes from there," said Rai.

The film is set to be released on December 21, 2018 and fans can expect updates about the film at regular intervals.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Moderna shares

Moderna's latest cancer trial has revived investor interest in its mRNA technology

iStock {Representational image}

Moderna shares nearly trebled after a cancer trial breakthrough: What changed?

  • Moderna shares jumped 177 per cent after the late-stage melanoma trial results.
  • The personalised treatment is designed around mutations found in each patient's tumour.
  • The result could give Moderna a new growth path as demand for its Covid vaccines has weakened.

Moderna has given investors something they have been waiting for since the Covid vaccine boom: a reason to believe its mRNA technology could become a much bigger business beyond infectious diseases.

Shares in the US drugmaker jumped 177 per cent to $174.38 on August 19 after Moderna and Merck reported positive results from a late-stage trial of an experimental personalised cancer treatment. It was Moderna's biggest one-day percentage gain since its 2018 stock market debut and added billions of dollars to its market value.

Keep ReadingShow less